ARCHIVES

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

This article is from The Cancer Letter archive.

Vol. 37 No. 5 | May 30, 2014

Download PDF Visit The Full Archive

Related Articles

Single-Letter Mutation Found Responsible For Waldenstrom’s

December 30, 2011

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001

Freireich Blasts Prevention Advocates, Defends Treatment

September 15, 1978

St. Jude Begins $100 Million Expansion Program

December 4, 1987

Advisors Say 10 Percent Payline “Not Tenable;” All NCI Programs Must Share Budget Cuts.

March 31, 2006

NIH Funding Opportunity: Outstanding Investigator Award In Cancer Research Available

June 11, 2014